Prof. Seema Singh

Dr. Seema Singh is a tenured Professor of Cell and Molecular Biology and an Associate Director of Education and Training at the Cancer Center and Research Institute. Her lab focuses on inflammation and immunobiology, especially studying these aspects in racially diverse patient populations. She has recently been interested in studying how adverse social exposures impact human physiology, creating a hormonal imbalance and inflammation to provide a fertile ground for cancer development. In breast cancer, she is exploring the epigenomic consequences of these systemic alterations promoting early onset and aggressive progression of certain breast cancer molecular subtypes. In addition, her lab is interested in whether the immune landscape of tumors is also impacted and if that can be utilized to predict responses to immune checkpoint therapy. Dr. Singh has been a prolific researcher with numerous publications and multiple US patents. She also co-founded a biotech start-up, Tatva Biosciences, to commercialize laboratory findings and find innovative solutions for effective cancer management. Her scientific and scholarly achievements have been recognized with various honors and awards. She has secured funding from the National Institutes of Health (NIH) and private foundations. She is actively engaged in the scientific community, serving as reviewer/chair on national and international grant study sections and as an editorial board member for several high-impact scientific journals.